|
1
|
Bridgewater J, Galle PR, Khan SA, Llovet JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol. 60:1268–1289. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Navaneethan U, Thosani N, Goodman A, Manfredi M, Pannala R, Parsi MA, Smith ZL, Sullivan SA, Banerjee S and Maple JT: ASGE Technology Committee. Radiofrequency ablation devices. VideoGIE. 2:252–259. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Strand DS, Cosgrove ND, Patrie JT, Cox DG, Bauer TW, Adams RB, Mann JA, Sauer BG, Shami VM and Wang AY: ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma. Gastrointest Endosc. 80:794–804. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Dolak W, Schreiber F, Schwaighofer H, Gschwantler M, Plieschnegger W, Ziachehabi A, Mayer A, Kramer L, Kopecky A, Schrutka-Kölbl C, et al: Austrian Biliary RFA Study Group: Endoscopic radiofrequency ablation for malignant biliary obstruction: A nationwide retrospective study of 84 consecutive applications. Surg Endosc. 28:854–860. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dutta AK, Basavaraju U, Sales L and Leeds JS: Radiofrequency ablation for management of malignant biliary obstruction: A single-center experience and review of the literature. Expert Rev Gastroenterol Hepatol. 11:779–784. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mizandari M, Kumar J, Pai M, Chikovani T, Azrumelashvili T, Reccia I and Habib N: Interventional radiofrequency ablation: A promising therapeutic modality in the management of malignant biliary and pancreatic duct obstruction. J Cancer. 9:629–637. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yang J, Wang J, Zhou H, Zhou Y, Wang Y, Jin H, Lou Q and Zhang X: Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: A randomized trial. Endoscopy. 50:751–760. 2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Andrasina T, Rohan T, Panek J, Kovalcikova P, Kunovsky L, Ostrizkova L and Valek V: The combination of endoluminal radiofrequency ablation and metal stent implantation for the treatment of malignant biliary stenosis - Randomized study. Eur J Radiol. 142(109830)2021.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Camus M, Napoléon B, Vienne A, Le Rhun M, Leblanc S, Barret M, Chaussade S, Robin F, Kaddour N and Prat F: Efficacy and safety of endobiliary radiofrequency ablation for the eradication of residual neoplasia after endoscopic papillectomy: A multicenter prospective study. Gastrointest Endosc. 88:511–518. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
So H, Oh CH, Song TJ, Lee HW, Hwang JS, Ko SW, Oh D, Park DH, Lee SS, Seo DW, et al: Feasibility and safety of endoluminal radiofrequency ablation as a rescue treatment for bilateral metal stent obstruction due to tumor ingrowth in the Hilum: A Pilot Study. J Clin Med. 10(952)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hu B, Sun B, Gao DJ, Wu J, Ye X, Xia MX and Wang TT: Initial experience of ERCP-guided radiofrequency ablation as the primary therapy for inoperable ampullary carcinomas. Dig Dis Sci. 65:1453–1459. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Gao DJ, Yang JF, Ma SR, Wu J, Wang TT, Jin HB, Xia MX, Zhang YC, Shen HZ, Ye X, et al: Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: A multicenter randomized controlled trial. Gastrointest Endosc. 94:91–100.e2. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Mizandari M, Ao G, Zhang Y, Feng X, Shen Q, Chen M, Lau W, Nicholls J, Jiao L and Habib N: Novel percutaneous radiofrequency ablation of portal vein tumor thrombus: Safety and feasibility. Cardiovasc Intervent Radiol. 36:245–248. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Suzuki H, Sekine Y, Saito K, Nakajima T, Sakairi Y, Yoshida S and Yoshino I: Innovative technique of transbronchial radiofrequency ablation for intrapulmonary tumors: A preliminary study in a rabbit model. J Bronchology Interv Pulmonol. 18:211–217. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sommer CM, Lemm G, Hohenstein E, Bellemann N, Stampfl U, Goezen AS, Rassweiler J, Kauczor HU, Radeleff BA and Pereira PL: CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: Specific technical aspects and clinical results. Cardiovasc Intervent Radiol. 36:731–737. 2013.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Li TF, Huang GH, Li Z, Hao CF, Ren JZ, Duan XH, Zhang K, Chen C, Han XW, Jiao DC, et al: Percutaneous transhepatic cholangiography and intraductal radiofrequency ablation combined with biliary stent placement for malignant biliary obstruction. J Vasc Interv Radiol. 26:715–721. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Itoi T, Isayama H, Sofuni A, Itokawa F, Tamura M, Watanabe Y, Moriyasu F, Kahaleh M, Habib N, Nagao T, et al: Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex-vivo pig liver. J Hepatobiliary Pancreat Sci. 19:543–547. 2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
den Brok MH, Sutmuller RP, van der Voort R, Bennink EJ, Figdor CG, Ruers TJ and Adema GJ: In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res. 64:4024–4029. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Rustagi T, Gleeson FC, Abu Dayyeh BK, Topazian MD and Levy MJ: Evaluation of effects of radiofrequency ablation of ex vivo liver using the 1-Fr wire electrode. J Clin Gastroenterol. 52:168–171. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Choi HH, Shin OR, Kim HK, Jeon BS, Park YW, Kim SW, Kim SS, Chae HS and Lee SV: Efficacy of endobiliary radiofrequency ablation using a novel endoluminal radiofrequency ablation catheter in a swine model. J Invest Surg. 32:731–737. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Atar M, Kadayifci A, Daglilar E, Hagen C, Fernandez-Del Castillo C and Brugge WR: Ex vivo human bile duct radiofrequency ablation with a bipolar catheter. Surg Endosc. 32:2808–2813. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Laleman W, van der Merwe S, Verbeke L, Vanbeckevoort D, Aerts R, Prenen H, Van Cutsem E and Verslype C: A new intraductal radiofrequency ablation device for inoperable biliopancreatic tumors complicated by obstructive jaundice: The IGNITE-1 study. Endoscopy. 49:977–982. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rathke H, Hamm B, Güttler F, Rathke J, Rump J, Teichgräber U and de Bucourt M: Comparison of four radiofrequency ablation systems at two target volumes in an ex vivo bovine liver model. Diagn Interv Radiol. 20:251–258. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lee KW, Lee JM, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Um SH, Lee HS, Chun HJ, et al: Novel ablation therapy using endoscopic irreversible electroporation in the bile duct: A pilot animal study. Clin Endosc. 54:413–419. 2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Uyanık SA, Öğüşlü U, Yılmaz B, Çevik H, Atlı E and Gümüş B: Percutaneous intraductal microwave ablation of malignant biliary strictures: Initial experience. AJR Am J Roentgenol. 215:753–759. 2020.PubMed/NCBI View Article : Google Scholar
|
